$23.47
-1.26-5.1%
Last update: Oct 16, 7:36 PM
$24.00
-0.73-2.95%
Beam Therapeutics Inc
BEAMNASDAQ
Wall Street analyst price targets and consensus rating for Beam Therapeutics (BEAM).
Price Target Range — 13 Quarters
Analyst Consensus — 18 Analysts
Rating Trend — Last 9 Months
